Indianapolis, IN, United States of America

Yi Wei

This inventor holds 5 USPTO granted patents and 3 EPO patents. Top assignee: Eli Lilly and Company. Active years: 2019-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi Wei. Retrieved from https://idiyas.com/inventor/yi-wei-zrf22koa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Yi Wei

Introduction

Yi Wei is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating liver diseases. With a total of 5 patents to his name, Yi Wei continues to push the boundaries of innovation in his field.

Latest Patents

Among his latest patents are two notable inventions. The first is focused on amino pyrimidine ssao inhibitors, which provides compounds of a specific formula, along with methods for treating patients suffering from liver disease. The second patent also revolves around amino pyrimidine compounds that are useful as SSAO inhibitors, detailing similar methods and processes for preparing these compounds. These inventions highlight his dedication to advancing medical treatments.

Career Highlights

Yi Wei is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation and research. His work at Eli Lilly has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to pharmaceutical science.

Collaborations

Some of his notable coworkers include Jingye Zhou and David Andrew Coates. Their collaborative efforts have undoubtedly enriched the research environment and fostered innovative solutions in their projects.

Conclusion

Yi Wei's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and ongoing research contribute significantly to the development of new treatments for liver diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…